Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2012
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220557 Liquid propellant-free formulation comprising an antimuscarinic drug
08/30/2012US20120220531 Surfactant protein d for the treatment of disorders associated with lung injury
08/30/2012US20120220526 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and other Disorders
08/30/2012US20120219644 Coconut oil-based intranasal composition and use
08/30/2012US20120219597 Pharmaceutical formulations for indibulin
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219547 Humanized Anti-TNFalpha Antibodies
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219525 Stable thickener formulations
08/30/2012US20120219509 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/30/2012US20120216802 Composition for inhalation
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2827782A1 Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine
08/30/2012CA2824500A1 Antibodies against human il33r and uses thereof
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492267A1 Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient
08/29/2012EP2491932A2 Use of biomarkers for monitoring the course of treatment of a pulmonary disease upon treatment with treprostinil
08/29/2012EP2491042A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
08/29/2012EP2491037A1 Compounds
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491007A1 Inhibitors of the microsomal prostaglandin e2 synthase-1
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012EP2490687A1 Compositions for treatment of cystic fibrosis and other chronic diseases
08/29/2012CN1997395B Drug having regulatory cell ligand contained in liposome
08/29/2012CN102652136A 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives
08/29/2012CN102652128A 4 -oxo- iH -quinoline- 3 - carboxamides as modulators of ATP -binding cassette transporters
08/29/2012CN102648977A Application of follistatin-related protein 1 in adjusting Na, K-ATPase activity
08/29/2012CN102648958A Traditional Chinese medicine enema for treating acute upper respiratory infections of children
08/29/2012CN102648944A Traditional Chinese medicine composition for treating infectious coryza of chicken and preparation method thereof
08/29/2012CN102648934A Traditional Chinese medicine composition for treating chronic simple rhinitis and preparation method thereof
08/29/2012CN102648927A Production technology of petasites lactone compound
08/29/2012CN102648922A Gamuzhuer medicinal latex preparation and preparation method thereof
08/29/2012CN102648921A Medicinal combination for treating non-small cell lung cancer
08/29/2012CN102648916A Treprostinil treatment for interstitial lung disease and asthma
08/29/2012CN102648905A Combined medicament for treating swine pneumonia and upper respiratory tract infection and preparation method thereof
08/29/2012CN102648902A Cough and asthma far infrared magnetic therapy patch
08/29/2012CN102204929B Chuihou powder preparation and preparation method thereof
08/29/2012CN102198065B Oral spray and preparation method thereof
08/29/2012CN102178730B Platycarya strobilacea sieb infructescence polyphenols extract as well as extracting method and application thereof
08/29/2012CN102145144B Traditional Chinese medicine preparation for treatment of asthma
08/29/2012CN102145113B Chinese medical composition capable of resolving phlegm and relieving asthma and preparation method thereof
08/29/2012CN102139067B Quality control method for antipyretic and antitoxic tablet
08/29/2012CN102133318B Chinese medicinal preparation for treating bronchial asthma
08/29/2012CN102058770B Traditional Chinese medicinal composition for clearing lung, resolving phlegm and relieving cough and asthma and preparation method thereof
08/29/2012CN102058666B Chinese medicinal preparation for treating acute upper respiratory tract infection and preparation method thereof
08/29/2012CN102038721B Pinus extract and application thereof
08/29/2012CN101953512B Coffee cigarette and preparation method thereof
08/29/2012CN101926458B Tea bag prepared from aerial part of hemlock parsley, preparation process and application thereof
08/29/2012CN101791382B Chinese herbal medicine combination for treating nasal bleeding
08/29/2012CN101717692B Artemisia rutifolia essential oil and extraction process and application thereof
08/29/2012CN101709251B Bee milk costus and amomum wine
08/29/2012CN101574475B Polygonatum particle and preparation method thereof
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101443344B Trehalose compound and pharmaceutical comprising the compound
08/29/2012CN101264305B Medicaments for treating no fever type common cold
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252797 Heterocyclic compounds as adenosine receptor antagonist
08/28/2012US8252268 Formoterol and mometasone aerosol formulations
08/28/2012CA2589744C Pyrrolinidium derivatives as m3 muscarinic receptors
08/28/2012CA2563302C Combinations of glycopyrrolate and beta2 adrenoceptor agonists
08/28/2012CA2519679C Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/23/2012WO2012111934A2 Pharmaceutical composition for preventing and treating inflammatory disease or asthma containing an extract of decaspermum fruticosum
08/23/2012WO2012111627A1 Nanoparticle containing prostaglandin i2 derivative
08/23/2012WO2012110770A2 Pharmaceutical composition
08/23/2012WO2012098342A8 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
08/23/2012WO2012090218A4 Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases
08/23/2012US20120216303 Novel therapeutic uses of human formyl peptide receptor antagonists
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
08/23/2012US20120214838 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/23/2012US20120214822 N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214801 Compositions and methods relating to novel compounds and targets thereof
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214789 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
08/23/2012US20120214780 Substituted porphyrins
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012US20120214730 Method of using heparin binding motif for treating asthma
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213855 Dosage forms for weakly ionizable compounds